Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 30

Sort by

Sort Order Select

Journal Articles

National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment

BD Cheson, JM Bennett, M Grever, N Kay, MJ Keating, S O'Brien, KR Rai

Blood (1996) 87 (12): 4990–4997.

https://doi.org/10.1182/blood.V87.12.4990.bloodjournal87124990

Published: 1996

Journal Articles

Chlorodeoxyadenosine and arabinosylcytosine in patients with acute myelogenous leukemia: pharmacokinetic, pharmacodynamic, and molecular interactions

V Gandhi, E Estey, MJ Keating, A Chucrallah, W Plunkett

Blood (1996) 87 (1): 256–264.

https://doi.org/10.1182/blood.V87.1.256.256

Published: 1996

Journal Articles

The value of high-dose systemic chemotherapy and intrathecal therapy for central nervous system prophylaxis in different risk groups of adult acute lymphoblastic leukemia

J Cortes, SM O'Brien, S Pierce, MJ Keating, EJ Freireich, HM Kantarjian

Blood (1995) 86 (6): 2091–2097.

https://doi.org/10.1182/blood.V86.6.2091.bloodjournal8662091

Published: 1995

Journal Articles

Interferon maintenance therapy for patients with chronic lymphocytic leukemia in remission after fludarabine therapy

S O'Brien, H Kantarjian, M Beran, LE Robertson, C Koller, S Lerner, MJ Keating

Blood (1995) 86 (4): 1298–1300.

https://doi.org/10.1182/blood.V86.4.1298.bloodjournal8641298

Published: 1995

Journal Articles

p16INK4A and p15INK4B gene deletions in primary leukemias

MA Haidar, XB Cao, T Manshouri, LL Chan, A Glassman, HM Kantarjian, MJ Keating, MS Beran, M Albitar

Blood (1995) 86 (1): 311–315.

https://doi.org/10.1182/blood.V86.1.311.bloodjournal861311

Published: 1995

Journal Articles

2-Chlorodeoxyadenosine therapy in patients with T-cell lymphoproliferative disorders

S O'Brien, R Kurzrock, M Duvic, H Kantarjian, S Stass, LE Robertson, E Estey, S Pierce, MJ Keating

Blood (1994) 84 (3): 733–738.

https://doi.org/10.1182/blood.V84.3.733.733

Published: 1994

Journal Articles

Long-term follow-up of patients with chronic lymphocytic leukemia treated with fludarabine as a single agent

MJ Keating, S O'Brien, H Kantarjian, W Plunkett, E Estey, C Koller, M Beran, EJ Freireich

Blood (1993) 81 (11): 2878–2884.

https://doi.org/10.1182/blood.V81.11.2878.2878

Published: 1993

Journal Articles

Fluorescent in situ hybridization and cytogenetic studies of trisomy 12 in chronic lymphocytic leukemia

SM Escudier, JM Pereira-Leahy, JW Drach, HU Weier, AM Goodacre, MA Cork, JM Trujillo, MJ Keating, M Andreeff

Blood (1993) 81 (10): 2702–2707.

https://doi.org/10.1182/blood.V81.10.2702.2702

Published: 1993

Journal Articles

Phase I study of Topotecan, a new topoisomerase I inhibitor, in patients with refractory or relapsed acute leukemia

HM Kantarjian, M Beran, A Ellis, L Zwelling, S O'Brien, L Cazenave, C Koller, MB Rios, W Plunkett, MJ Keating

Blood (1993) 81 (5): 1146–1151.

https://doi.org/10.1182/blood.V81.5.1146.1146

Published: 1993

Journal Articles

Response assessment in chronic lymphocytic leukemia after fludarabine plus prednisone: clinical, pathologic, immunophenotypic, and molecular analysis [see comments]

LE Robertson, YO Huh, JJ Butler, WC Pugh, C Hirsch-Ginsberg, S Stass, H Kantarjian, MJ Keating

Blood (1992) 80 (1): 29–36.

https://doi.org/10.1182/blood.V80.1.29.29

Published: 1992

Journal Articles

Intensive chemotherapy with mitoxantrone and high-dose cytosine arabinoside followed by granulocyte-macrophage colony-stimulating factor in the treatment of patients with acute lymphocytic leukemia

HM Kantarjian, EH Estey, S O'Brien, E Anaissie, M Beran, MB Rios, MJ Keating, J Gutterman

Blood (1992) 79 (4): 876–881.

https://doi.org/10.1182/blood.V79.4.876.876

Published: 1992

Journal Articles

Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine (2-CdA)

EH Estey, R Kurzrock, HM Kantarjian, SM O'Brien, KB McCredie, M Beran, C Koller, MJ Keating, C Hirsch-Ginsberg, YO Huh

Blood (1992) 79 (4): 882–887.

https://doi.org/10.1182/blood.V79.4.882.882

Published: 1992

Journal Articles

Significance of the P210 versus P190 molecular abnormalities in adults with Philadelphia chromosome-positive acute leukemia

HM Kantarjian, M Talpaz, K Dhingra, E Estey, MJ Keating, S Ku, J Trujillo, Y Huh, S Stass, R Kurzrock

Blood (1991) 78 (9): 2411–2418.

https://doi.org/10.1182/blood.V78.9.2411.2411

Published: 1991

Journal Articles

Fludarabine therapy in macroglobulinemic lymphoma

HM Kantarjian, R Alexanian, CA Koller, R Kurzrock, MJ Keating

Blood (1990) 75 (10): 1928–1931.

https://doi.org/10.1182/blood.V75.10.1928.1928

Published: 1990

Journal Articles

Treatment of poor-prognosis, newly diagnosed acute myeloid leukemia with ara-C and recombinant human granulocyte-macrophage colony- stimulating factor

EH Estey, D Dixon, HM Kantarjian, MJ Keating, K McCredie, GP Bodey, R Kurzrock, M Talpaz, EJ Freireich, AB Deisseroth

Blood (1990) 75 (9): 1766–1769.

https://doi.org/10.1182/blood.V75.9.1766.1766

Published: 1990

Journal Articles

Modulation of arabinosylcytosine metabolism by arabinosyl-2- fluoroadenine in lymphocytes from patients with chronic lymphocytic leukemia: implications for combination therapy

V Gandhi, B Nowak, MJ Keating, W Plunkett

Blood (1989) 74 (6): 2070–2075.

https://doi.org/10.1182/blood.V74.6.2070.2070

Published: 1989

Journal Articles

Fludarabine: a new agent with major activity against chronic lymphocytic leukemia

MJ Keating, H Kantarjian, M Talpaz, J Redman, C Koller, B Barlogie, W Velasquez, W Plunkett, EJ Freireich, KB McCredie

Blood (1989) 74 (1): 19–25.

https://doi.org/10.1182/blood.V74.1.19.19

Published: 1989

Journal Articles

Identification of risk groups for development of central nervous system leukemia in adults with acute lymphocytic leukemia

HM Kantarjian, RS Walters, TL Smith, MJ Keating, B Barlogie, KB McCredie, EJ Freireich

Blood (1988) 72 (5): 1784–1789.

https://doi.org/10.1182/blood.V72.5.1784.1784

Published: 1988

Journal Articles

Antileukemic effect of recombinant tumor necrosis factor alpha in vitro and its modulation by alpha and gamma interferons

M Beran, KB McCredie, MJ Keating, JU Gutterman

Blood (1988) 72 (2): 728–738.

https://doi.org/10.1182/blood.V72.2.728.728

Published: 1988

Journal Articles

Clinical investigation of human alpha interferon in chronic myelogenous leukemia

M Talpaz, HM Kantarjian, KB McCredie, MJ Keating, J Trujillo, J Gutterman

Blood (1987) 69 (5): 1280–1288.

https://doi.org/10.1182/blood.V69.5.1280.1280

Published: 1987

NARROW

National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment

Chlorodeoxyadenosine and arabinosylcytosine in patients with acute myelogenous leukemia: pharmacokinetic, pharmacodynamic, and molecular interactions

The value of high-dose systemic chemotherapy and intrathecal therapy for central nervous system prophylaxis in different risk groups of adult acute lymphoblastic leukemia

Interferon maintenance therapy for patients with chronic lymphocytic leukemia in remission after fludarabine therapy

p16INK4A and p15INK4B gene deletions in primary leukemias

2-Chlorodeoxyadenosine therapy in patients with T-cell lymphoproliferative disorders

Long-term follow-up of patients with chronic lymphocytic leukemia treated with fludarabine as a single agent

Fluorescent in situ hybridization and cytogenetic studies of trisomy 12 in chronic lymphocytic leukemia

Phase I study of Topotecan, a new topoisomerase I inhibitor, in patients with refractory or relapsed acute leukemia

Response assessment in chronic lymphocytic leukemia after fludarabine plus prednisone: clinical, pathologic, immunophenotypic, and molecular analysis [see comments]

Intensive chemotherapy with mitoxantrone and high-dose cytosine arabinoside followed by granulocyte-macrophage colony-stimulating factor in the treatment of patients with acute lymphocytic leukemia

Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine (2-CdA)

Significance of the P210 versus P190 molecular abnormalities in adults with Philadelphia chromosome-positive acute leukemia

Fludarabine therapy in macroglobulinemic lymphoma

Treatment of poor-prognosis, newly diagnosed acute myeloid leukemia with ara-C and recombinant human granulocyte-macrophage colony- stimulating factor

Modulation of arabinosylcytosine metabolism by arabinosyl-2- fluoroadenine in lymphocytes from patients with chronic lymphocytic leukemia: implications for combination therapy

Fludarabine: a new agent with major activity against chronic lymphocytic leukemia

Identification of risk groups for development of central nervous system leukemia in adults with acute lymphocytic leukemia

Antileukemic effect of recombinant tumor necrosis factor alpha in vitro and its modulation by alpha and gamma interferons

Clinical investigation of human alpha interferon in chronic myelogenous leukemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only